FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39235911000001104: Vitrakvi 100mg capsules (Bayer Plc) 56 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Mar 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
151341000001110 Vitrakvi 100mg capsules (Bayer Plc) 56 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
151351000001113 Vitrakvi 100mg capsules (Bayer Plc) 56 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has specific active ingredient Larotrectinib sulfate true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has AMP Vitrakvi 100mg capsules (Bayer Plc) true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Is a Larotrectinib 100mg capsules 56 capsule true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Larotrectinib false Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has specific active ingredient Larotrectinib sulfate false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start